|

GLB-001 Clinical Trials

2 actively recruiting trials across 1 location

Also known as: GLB-C183-A-2

Pipeline

Phase 1: 2

Top Sponsors

  • Hangzhou GluBio Pharmaceutical Co., Ltd.1
  • GluBio Therapeutics Inc.1

Indications

  • Acute Myeloid Leukemia2
  • Myelodysplastic Syndromes2
  • Cancer2
  • Myelofibrosis1
  • Essential Thrombocythemia1

Other1 trial

A Study of GLB-001 in Patients With Myeloid Malignancies
Phase 1

Duarte, California1 trial

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.